Pharmacokinetics and metabolism of nicotine.

Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 2

Abstract

Nicotine (NIC), the major constituent of tobacco, is responsible for the compulsive use of tobacco. Advances in understanding of the pharmacokinetics and metabolism of NIC have been made rapidly over the past decade. The application of highly sensitive gas chromatography/mass spectrometry led to the identification and quantitation of new NIC metabolites as well as characterization of new pathways of NIC biotransformation. This review summarizes findings from human and animal studies concerning NIC kinetics and biotransformation as well as describes the factors that influence these processes. Recently, large individual, racial and species differences in the metabolism of NIC have been well documented. The differences in the metabolism of NIC may be a result of genetic, environmental, and developmental host influences. We review the scientific evidence from studies that supports a role for genetic mechanisms responsible for variability in the profile and the rate of the NIC metabolism. Actually, the majority of the genetic studies focus on the characterization of the CYP2A6 gene polymorphism, and on determining the relationship between the phenotype of NIC metabolism and the genotype of the CYP2A6 gene. There is good evidence that genetic polymorphisms associated with NIC metabolism are an important factor responsible for susceptibility to NIC dependence. It is anticipated that genetic findings can lead to the identification of individuals at a greater risk for tobacco addiction and will be used for more effective treatment and prevention strategies to reduce smoking.

Authors and Affiliations

Piotr Tutka, Jerzy Mosiewicz, Marian Wielosz

Keywords

Related Articles

Prostacyclin in the cardiovascular system: new aspects and open questions.

Several indications exist that prostacyclin (PGI(2)) release in the cardiovascular system might be affected by cyclooxygenase (COX)-2-specific inhibitors. This could reflect an inhibition of PGI(2) synthesis in the endot...

Pseudo-epileptic seizures in children are not associated with enhanced plasma level of allopregnanolone.

Among neurosteroids, allopregnanolone is the most potent endogenous positive modulator of GABA(A) receptors, and disturbances in its release may play a role in pathomechanism of some neurological and psychiatric disorder...

Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.

The interaction between uncompetitive NMDA receptor antagonists (memantine and ketamine), and morphine (mu-opioid receptor agonist) and pentazocine (kappa-opioid receptor agonist) was studied in the writhing test in mice...

Antitumor effects of a selenium heteropoly complex in K562 cells.

The aim of this study was to investigate the anti-tumor effects and mechanism of the selenium heteropoly compound (C(2)H(10)N(2))(5)(NH(4))(4)H(2)[Se(2)W(10)V(8)O(62)].9H(2)O (SeWV) in K562 cells. The results showed that...

Influence of zinc hydroaspartate on the anti-inflammatory and gastric activity of ketoprofen in rats.

Background: The study's aim was to evaluate the anti-inflammatory effect and influence on gastric mucosa after the combined administration of ketoprofen and zinc hydroaspartate (ZHA, 60 mg/kg). Methods: Antiedematous act...

Download PDF file
  • EP ID EP91032
  • DOI -
  • Views 81
  • Downloads 0

How To Cite

Piotr Tutka, Jerzy Mosiewicz, Marian Wielosz (2005). Pharmacokinetics and metabolism of nicotine.. Pharmacological Reports, 57(2), 143-153. https://europub.co.uk/articles/-A-91032